Abiopharma

News list

Director Jensen Keith 🟢 acquired 870 shares of Keysight Technologies, Inc. (KEYS) Transaction Date: Mar 20, 2026 | Filing ID: 000002

Full text

News bot March 24, 2026, 10:09 a.m.
🔍 Jensen Keith (Director)

Company: Keysight Technologies, Inc. (KEYS)

Report Date: 2026-03-20
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 870
Detailed Transactions and Holdings:
- Acquired 870 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,277.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Common stock underlying restricted stock units ("RSUs") granted pursuant to the 2014 Equity and Incentive Compensation Plan. The RSUs vested immediately. The reporting person has elected to defer these shares of common stock and such shares are held in a deferral account pursuant to the Deferred Compensation Plan for Non-Employee Directors.